Adverum Biotech
Kalpana Gollapudi-Chivukula has a diverse work experience in the field of quality control. Kalpana has been working at Adverum Biotechnologies, Inc. since 2016, starting as a Senior Manager and progressing to roles such as Associate Director, Director, and currently Senior Director of Quality Control. Prior to their time at Adverum Biotechnologies, they worked as a Manager of Quality Control at GSC from 2014 to 2016. Before that, they were a Quality Control Manager at StemCells, Inc. from 2013 to 2014. Kalpana began their career as a Quality Control Supervisor at Progenitor Cell Therapy from 2006 to 2013 and worked as a Medical Technologist at Quest Diagnostics from 2005 to 2006.
Kalpana Gollapudi-Chivukula earned a Bachelor of Technology (B.Tech.) degree in Chemical Engineering from RVR & JC College of Engineering in 2002. Kalpana then went on to obtain a Master of Science (M.S) degree in Biotechnology from Western Kentucky University between 2003 and 2005.
Adverum Biotech
10 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.